Company Encyclopedia
View More
name
CXO
CP40006.SH
News
View More

Pharmaron Shareholders Back Board Changes and Governance Policy Upgrades at 2025 EGM

Pharmaron Beijing Co., Ltd. held its first extraordinary general meeting of 2025, with shareholders approving all proposed resolutions, including board changes and governance policy upgrades. The meeting saw participation from 48.6% of voting share capital. The changes aim to enhance regulatory compliance, oversight of capital use, and board independence, potentially boosting investor confidence. The latest analyst rating for Pharmaron's stock is a Buy with a HK$28.10 price target.

Tip Ranks·
HK
03759
-3.87%
SZ
300759
-1.46%
Tip Ranks·
HK
03759
-3.87%
SZ
300759
-1.46%

Pharmaron Beijing Sets Out Board and Committee Structure for Third Board Session

Pharmaron Beijing Co., Ltd. has announced the composition of its board of directors and the structure of its four key board committees: Audit, Remuneration and Appraisal, Nomination, and Strategy. This move aims to enhance corporate governance and transparency. The company operates in the pharmaceutical and life sciences sector, providing research and development services. The latest analyst rating for its stock (HK:3759) is a Buy with a target price of HK$28.10.

Tip Ranks·
HK
03759
-3.87%
SZ
300759
-1.46%
Tip Ranks·
HK
03759
-3.87%
SZ
300759
-1.46%

Pharmaron Beijing Files Director List with HKEX

Pharmaron Beijing Co. Ltd. has filed its latest list of directors with the Hong Kong Stock Exchange. The Board is led by Dr. Lou Boliang as chairman. The filing details the roles of executive, non-executive, and independent non-executive directors across four committees: Audit, Remuneration and Appraisal, Nomination, and Strategy. This filing is for informational purposes and not financial advice.

Reuters·
HK
03759
-3.87%
SZ
300759
-1.46%
Reuters·
HK
03759
-3.87%
SZ
300759
-1.46%

Pharmaron Beijing Appoints Li Shing Chung Gilbert as Employee Representative Director

Pharmaron Beijing Co. Ltd. has appointed Mr. Li Shing Chung Gilbert as the employee representative director to its board. The board now includes several members, including Dr. Lou Boliang and Mr. Lou Xiaoqiang. This announcement was made via the Hong Kong Stock Exchange's Issuer Information Service.

Reuters·
HK
03759
-3.87%
SZ
300759
-1.46%
Reuters·
HK
03759
-3.87%
SZ
300759
-1.46%

Pharmaron Beijing Co. Ltd. Held Extraordinary General Meeting

Pharmaron Beijing Co. Ltd. held its First Extraordinary General Meeting of 2025 on December 18, where shareholders approved the appointments of independent non-executive directors, amendments to the Articles of Association, and an increase in registered capital.

Reuters·
HK
03759
-3.87%
SZ
300759
-1.46%
Reuters·
HK
03759
-3.87%
SZ
300759
-1.46%
Posts
View More
© 2025 Longbridge｜Disclaimer